It said products marketed to treat specific pains, such as migraine, were identical to one another.
Nurofen said the products had been "designed to help the consumer easily navigate our range", particularly in groceries where there was no
"Consumer research indicates that 9 in 10 people (88%) look for pain relief for a specific type of pain (eg headache, migraine, back pain) and 7 in
10 (71%) say pain-specific packs help them decide which product is best for their needs," said Dr Aomesh Bhatt, regulatory and medical affairs
director for Nurofen.
The products affected by the Australian court order include Nurofen Back Pain, Nurofen Period Pain, Nurofen Migraine Pain and Nurofen Tension
The Australian Competition and Consumer Commission (ACCC) watchdog had brought the matter to court earlier this year.
The ACCC said the court had found that the firm had "engaged in misleading conduct in contravention of the Australian consumer law by representing
that its Nurofen Specific Pain products were each formulated to treat a specific type of pain, when the products are identical".
Each product contained the same active ingredient, ibuprofen lysine 342mg.
So, basically they packaged identical product differently and then charged more. Tsk.
Location: Riverton, South Australia
Theme: Windows XP Silver
Member Is Offline
Mood: Gone crazy, Back soo
Post 500248 posted on 15-12-2015 at 06:19
Of course we all know that red cars go faster, too. If people are prepared to pay more for their marketing, more fool them. It always pays to
understand what the active ingredient is, and does, before spending your hard earned cash on any medication that has not been prescribed by your GP.
We had some silly alternative medicine pusher attempt to convince us that a particular concoction he was selling was so good he took double the
You are a guest, as a guest you can only see a maximum of 3 posts per thread.